https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 The clinical profile of NMOSD in Australia and New Zealand https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42666 Wed 31 Aug 2022 14:05:33 AEST ]]> What is the “optimal” target mismatch criteria for acute ischemic stroke? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:43675 P = 0.005), whereas there was no such association between reperfusion and an excellent outcome with any of the CCM criteria (all p > 0.05). Notably, in IVT-LVO cohort, 58.2% of the PIM-DT positive patients achieved an excellent outcome compared with 31.0% in non-mismatch patients following successful recanalization (P = 0.006).]]> Wed 28 Sep 2022 14:35:18 AEST ]]> Incidence and prevalence of NMOSD in Australia and New Zealand https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34644 Wed 22 May 2019 14:48:36 AEST ]]> Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42294 Fri 19 Aug 2022 14:58:38 AEST ]]> MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49799 Fri 02 Jun 2023 17:06:47 AEST ]]>